Drugs & Targets FDA campaign aims to prevent e-cigarette use among AI/AN youth June 10, 2022Vol.48 No.23
In Brief Reena Philip named associate director of biomarkers and precision oncology at OCE June 03, 2022Vol.48 No.22
Drugs & Targets FDA approves two Opdivo-based regimens in unresectable advanced or metastatic ESCC June 03, 2022Vol.48 No.22
Drugs & Targets FDA approves Kymriah in relapsed or refractory follicular lymphoma June 03, 2022Vol.48 No.22
Drugs & Targets FDA grants priority review to Omblastys in pediatric CNS/leptomeningeal metastasis from neuroblastoma June 03, 2022Vol.48 No.22
Drugs & Targets FDA grants Fast Track designation to PDS0101 + Keytruda in recurrent or metastatic HPV16-positive HNC June 03, 2022Vol.48 No.22
Capitol Hill House Republicans seek information on “me-too” drugs developed in China May 27, 2022Vol.48 No.21By Alice Tracey
Drugs & Targets FDA grants marketing authorization to Parsortix System for liquid biopsy in MBC May 27, 2022Vol.48 No.21
Drugs & Targets FDA approves Tibsovo + Vidaza in IDH1-mutant newly diagnosed AML May 27, 2022Vol.48 No.21
Drugs & Targets Friends study: drugs that earn Breakthrough Therapy Designation at FDA provide maximum benefit in lung cancer May 27, 2022Vol.48 No.21
